Sorrento Therapeutics Inc. (SRNE)

4.16
0.39 10.20
NASDAQ : Health Technology
Prev Close 3.77
Open 3.82
Day Low/High 3.70 / 4.16
52 Wk Low/High 1.39 / 6.50
Volume 8.30M
Avg Volume 4.21M
Exchange NASDAQ
Shares Outstanding 164.53M
Market Cap 626.87M
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

It is important to note that watching for a reversal is much different than being short.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Seeing Good Action in Several Stocks, Buying More MJ, Gold

Seeing Good Action in Several Stocks, Buying More MJ, Gold

It is a very different market environment now which can be very rewarding depending on your style.

Building in Biotech, Adding to Twitter

Building in Biotech, Adding to Twitter

The challenge of this market is to keep finding new buy entries as more and more stocks become extended.

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic

What drives the trading action are structural issues, not macroeconomic news events or political drama.

There Is Still Plenty of Strong, Tradable Action

There Is Still Plenty of Strong, Tradable Action

This market may be extended by just about any measure, but that doesn't mean you should be fighting it.

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits

Inertia is your biggest enemy in this market.

The January Effect Is on Time This Year

The January Effect Is on Time This Year

I continue to believe that biotech and biopharma stocks will outperform in 2018.

Biotechs Rise and Oil Falls

Stocks remain pretty much flat-lined, with the main indices trading in a very narrow range on light volume. In fact, oil is one of today's few real movers, down nearly 3%. Elsewhere in the markets: Foot Locker is getting a little lift after Citigrou...